Diquafosol tetrasodium: a novel dry eye therapy

Author： Nichols Kelly K   Yerxa Ben   Kellerman Donald J  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.1, 2004-01, pp. : 47-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjögren's syndrome

By Bremond-Gignac Dominique   Gicquel Jean-Jacques   Chiambaretta Frédéric  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 6, 2014-06 ,pp. : 905-913

Informa Healthcare

Access to resources Recommend Favorite

Diquafosol: DE 089, Diquafosol Tetrasodium, INS 365, INS 365 Ophthalmic, INS 365 Respiratory, KPY 998

By Limited A.I.  

Drugs in R&D, Vol. 4, Iss. 6, 2003-01 ,pp. : 359-362

Adis International

Access to resources Recommend Favorite

Ocular Pharmacokinetics and Safety of Ciclosporin, a Novel Topical Treatment for Dry Eye

By Tang-Liu Diane D.-S.   Acheampong Andrew  

Clinical Pharmacokinetics, Vol. 44, Iss. 3, 2005-01 ,pp. : 247-261

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of dry eye

By Dogru Murat   Tsubota Kazuo  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 3, 2011-02 ,pp. : 325-334

Informa Healthcare

Access to resources Recommend Favorite

Dry Eye in the Elderly

By Terry M.A.  

Drugs & Aging, Vol. 18, Iss. 2, 2001-02 ,pp. : 101-107

Adis International

Access to resources Recommend Favorite